Jeisys Density
Monopolar RF Tightening · High-intensity monopolar RF (Thermage rival)
New Jeisys Density pricing is not published; used and refurbished systems trade around $15k–$30k. Jeisys Density holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: Monopolar RF cleared for electrocoagulation and hemostasis in dermatologic/general surgery — no specific tightening indication
Last verified: August 6, 2026 · How we verify
New: —|Used: $15k–$30kmarket estimate, no email required
| Manufacturer | Jeisys |
|---|---|
| Company | Owner: Archimed SAS (French healthcare private equity, via MED Platform II) (private equity owned, since 2024) · Distribution: hybrid (direct + distributor) |
| Category | RF Microneedling, Tightening & HIFU |
| Technology | High-intensity monopolar RF (Thermage rival) |
| FDA status | FDA Cleared |
| New price range | Not published |
| Used price range | $15k–$30k |
| Consumables | Not published |
| Launch year | 2021 |
| Last verified | August 6, 2026 |
Bottom line
Jeisys's direct run at Thermage FLX — a no-needle, no-downtime monopolar RF tightening device from the same Korean manufacturer that builds Cynosure's Potenza, sold in the US through Jeisys Medical North America. The pitch: sequential monopolar-plus-bipolar RF in one pulse at device and consumable costs meaningfully below Thermage, letting you sell a Thermage-class treatment at a friendlier price. The catch is brand: patients search "Thermage," not "Density" — you'll market the outcome. US service infrastructure is still being proven; factor that into negotiation.
Overview
Korean Thermage competitor entering Western markets
How it works
The science
Monopolar RF drives energy deep into the dermis and subcutaneous fibrous septae (return pad completes the circuit): bulk volumetric heating, immediate collagen contraction, months of neocollagenesis for face and body laxity. Density's twist: monopolar and bipolar RF delivered sequentially within a single pulse, which Jeisys claims yields substantially more collagen stimulation than monopolar alone. Integrated contact cooling; one to two treatments spaced 4-6 months; results build 2-6 months.
Patented tech
Sequential monopolar+bipolar delivery, Smart Adjustable Cooling (five levels), Real-Time Auto Calibration adjusting energy against tissue feedback — functionally an impedance-based auto-dosing system similar in concept to Thermage's AccuREP.
Origin
Seoul, South Korea (Jeisys Medical — the OEM behind Cynosure's Potenza); US ops via Jeisys Medical North America (Burlington, MA).
FDA & regulatory status
What it's actually cleared for:
Monopolar RF cleared for electrocoagulation and hemostasis in dermatologic/general surgery — no specific tightening indication
510(k) numbers
K230663; K250065
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Recent industry events
How we source company dataOwnership and corporate changes at Jeisys that can affect warranty, service and parts availability.
- Oct 2024
Archimed takes Jeisys Medical private for $742M
Take-privateFrench healthcare investor Archimed acquired 100% of Jeisys Medical via a take-private tender offer at KRW 13,000/share (20.8% premium), total KRW 990B ($742M; EUR 668M), completed October 2024 with delisting from the Korea Exchange.
Source: Archimed press release; KED Global
Treatment economics
What practices charge
Full-face/neck $1,200-2,500 — deliberately undercutting Thermage FLX's typical $2,500-4,500 — with body zones priced similarly. Single-session-with-annual-maintenance model.
Consumables & recurring cost
Like Thermage, single-use tips with fixed shot counts; per-treatment tip cost reported below Thermage's $600-900+ but exact US pricing varies — verify with Jeisys. 4-6 treatments weekly still means tens of thousands annually in tips.
Ideal for
Best-fit practice
Practices losing tightening patients to Thermage providers who want that revenue at lower entry cost, or Potenza owners who trust the Jeisys build. Patients 40-65, mild-moderate laxity, needle-averse, zero downtime, $1,500+ once-a-year treatment.
Compliance
Medical director & delegation
Class II electrosurgical device requiring physician oversight in most states; commonly delegated to RNs/NPs after manufacturer training — verify locally.
Contraindications & screening
Pacemakers/defibrillators and implanted electronics are the hard stop for monopolar RF; also metal implants near the area, pregnancy, active skin disease at the site.
Ownership
Warranty & service
~1-year standard typical for new US entrants, extended negotiable — get terms in writing and pressure-test the young North America service bench (loaner policy, phone support).
Resale & used market
Essentially no US secondary market yet — no used-price erosion to point to, but no proven exit either; expect Korean-brand discounting steeper than Thermage's once units circulate.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.